Page last updated: 2024-10-30

mechlorethamine and B-Cell Lymphoma

mechlorethamine has been researched along with B-Cell Lymphoma in 5 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Research Excerpts

ExcerptRelevanceReference
"Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle."7.81Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015)
"Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle."3.81Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015)
"To determine the long-term outcome of patients presenting with synchronous lymphoma and severe liver dysfunction and to describe the outcome of patients treated with initial mechlorethamine-based therapy used as a bridge to more conventional chemotherapy."3.72Therapeutic options in patients with lymphoma and severe liver dysfunction. ( Ansell, SM; Colgan, JP; Fonseca, R; Ghobrial, IM; Habermann, TM; Inwards, DJ; Markovic, SN; Micallef, IN; Pereira, DL; Porrata, LF; White, WL; Witzig, TE; Wolf, RC, 2004)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malachowski, SJ1
Sun, J1
Chen, PL1
Seminario-Vidal, L1
Back, AR1
Schleis, SE1
Smrkovski, OA1
Lee, J1
Smith, AN1
Phillips, JC1
Ghobrial, IM1
Wolf, RC1
Pereira, DL1
Fonseca, R1
White, WL1
Colgan, JP1
Habermann, TM1
Inwards, DJ1
Markovic, SN1
Ansell, SM1
Micallef, IN1
Porrata, LF1
Witzig, TE1
Bachmeyer, C1
Orlandini, V1
Aractingi, S1
Rysenga, E1
Linden, MD1
Carey, JL1
Ross, CW1
Schnitzer, B1
Sawdyk, M1
Maeda, K1

Reviews

1 review available for mechlorethamine and B-Cell Lymphoma

ArticleYear
Diagnosis and Management of Cutaneous B-Cell Lymphomas.
    Dermatologic clinics, 2019, Volume: 37, Issue:4

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; An

2019

Other Studies

4 other studies available for mechlorethamine and B-Cell Lymphoma

ArticleYear
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
    Veterinary and comparative oncology, 2015, Volume: 13, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph

2015
Therapeutic options in patients with lymphoma and severe liver dysfunction.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies, Monoclona

2004
Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma.
    The British journal of dermatology, 2006, Volume: 154, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clobetasol; Humans; Lymphoma, B-Cell; Lymphom

2006
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Archives of pathology & laboratory medicine, 1995, Volume: 119, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce

1995